GliomaGen: Conditional Diffusion for Post-Treatment Glioma MRI Generation
GliomaGen is a generative diffusion model tailored for synthesizing post-treatment glioma MRI images based on anatomical masks. It leverages a modified Med-DDPM architecture to create high-fidelity MRI images conditioned on segmented anatomical features.
Model Overview
GliomaGen aims to address data scarcity in post-treatment glioma segmentation tasks by expanding existing datasets with synthetic, high-quality MRI volumes. The model takes anatomical masks as input and generates multi-modal MRI scans conditioned on segmentation labels.
Model Performance
Quantitative Metrics
Modality | FID (↓) | KID (↓) | MS-SSIM (↑) |
---|---|---|---|
t1c | 55.20 ± 3.74 | 0.0293 ± 0.0019 | 0.7647 ± 0.2106 |
t2w | 54.99 ± 3.23 | 0.0291 ± 0.0010 | 0.6513 ± 0.2881 |
t1n | 58.46 ± 3.86 | 0.0305 ± 0.0011 | 0.7005 ± 0.2585 |
t2f | 70.42 ± 4.17 | 0.0370 ± 0.0018 | 0.7842 ± 0.1551 |
Usage
To use GliomaGen for MRI generation, see the GitHub repository.
BraTS 2024 Adult Post-Treatment Glioma-Synthetic
Alongisde GliomaGen, a synthetic dataset of $N=2124$ MR images is released on HuggingFace.
Inference Providers
NEW
This model isn't deployed by any Inference Provider.
🙋
Ask for provider support
HF Inference deployability: The model has no library tag.
Evaluation results
- FID (t1c) on BraTS2024 Adult Post-Treatment Gliomaself-reported55.2028 ± 3.7446
- FID (t2w) on BraTS2024 Adult Post-Treatment Gliomaself-reported54.9974 ± 3.2271
- KID (t1c) on BraTS2024 Adult Post-Treatment Gliomaself-reported0.0293 ± 0.0019
- MS-SSIM (t1c) on BraTS2024 Adult Post-Treatment Gliomaself-reported0.7647 ± 0.2106